We report a case of a parturient who was well antenatally but presented with oliguria following delivery. The possibility of post-partum pre-eclampsia was obscured by simultaneous post-partum haemorrhage. Ergometrine was given and she suffered an eclamptic seizure shortly after. We discuss the diagnostic difficulties presented by simultaneous presentation of post-partum pre-eclampsia and haemorrhage and the likelihood that ergometrine precipitated eclampsia in a patient at risk. While ergometrine is an effective drug for the management of uterine atony, its potential role in precipitating eclampsia must be considered.
CASE HISTORY
A 30-year-old nulliparous patient with no obstetric problems presented for elective lower segment caesarean section at term for breech presentation. Besides being morbidly obese, with a body mass index of 42 kg/m 2 , she was otherwise well. Preoperatively, her blood pressure was 142/81 mmHg and her urine Dipstix showed trace albumin. The preoperative haemoglobin was normal. A subarachnoid block was performed and the early perioperative course was uneventful. Blood loss was 300 ml and 1.5 litres of crystalloid were infused perioperatively. The total operative time was 50 minutes.
Ten hours postoperatively, she was found to have post-partum haemorrhage. Her blood loss was estimated to be 800 ml over the last four hours and she had developed oliguria of 50 ml over 10 hours. She was haemodynamically stable, with a normal blood pressure of 120 to 130/80 to 90 mmHg and heart rate of 90 to 100 b/min. Besides mild pain over the operative site, she had no other signs or symptoms. A presumptive diagnosis of hypovolaemia with compensatory tachycardia was made and a fluid challenge of one litre of Hartmann's solution was given. The uterus was not easily palpated due to obesity. An infusion of 30 units oxytocin in 500 ml dextrose-saline over four hours was started and intravenous ergometrine 250 μg administered as a slow bolus. One hour later in the ward, the patient suffered a witnessed generalised tonic-clonic seizure lasting four minutes. The blood pressure was noted to be 150/100 mmHg and a diagnosis of post-partum eclampsia was made. She had post-ictal confusion and drowsiness with a Glasgow Coma Score of 9 (E2V3M4). As a result, she was intubated and sent for a CT head scan which was unremarkable. Magnesium sulphate 4 g intravenously was given prior to transfer to the radiology suite.
The diagnosis of eclampsia was supported in the intensive care unit (ICU) based on 3+ albumin on the urine dipstick and a postoperative uric acid concentration of 469 mmol/l. The haemoglobin concentration was 7.4 g/dl and the patient was transfused two units of packed red blood cells. Her coagulation profile, urea, electrolytes, creatinine, glucose and liver function tests were otherwise normal. The serum sodium was noted to be 135 mmol/l. A magnesium infusion was continued at 1 g/h and titrated to therapeutic levels. With transfusion of blood products, the urine output improved to 50 to 100 ml/h in the ICU.
The patient was extubated uneventfully three hours after intubation, once she had regained full consciousness, and was oriented in time, place and person. She remained well on intranasal oxygen at 2 l/min. The blood pressure rose from 120/80 mmHg at admission to ICU to 170/105 mmHg. A labetalol infusion was commenced but converted to oral dosing because the blood pressure had normalised by the next day. There were no further seizures and she was discharged from the ICU on the third day.
DISCUSSION
The major points of interest in this case report are the onset of seizure after ergometrine administration and its possible causative role, and the reminder this case serves that eclampsia may occur post-partum and without antecedent hypertension, especially in the presence of hypovolaemia.
In our patient with post-partum haemorrhage, the cause of oliguria was initially ascribed entirely to hypovolaemia. The absence of hypertension obscured the differential diagnosis of pre-eclampsia. Though hypertension is considered the hallmark of pre-eclampsia, it may be absent in up to 16% of cases 1 . In addition, 38% of patients may actually have no previous proteinuria and hypertension prior to the first convulsion 2 . Hence, the diagnosis of pre-eclampsia was only made retrospectively, when the patient developed eclampsia.
The difficulty in obtaining accurate blood pressure measurements non-invasively in a morbidly obese patient 3 may also have contributed to the diagnostic difficulties.
Postoperative blood loss may have masked the development of hypertension. Later, when the anaemia and hypovolaemia were corrected in the ICU, the blood pressure rose into the hypertensive range, requiring treatment with an intravenous labetalol infusion. In a similar case in which eclampsia developed after post-partum haemorrhage, there was no hypertension prior to the convulsions. Instead, the patient had a brief period of hypotension secondary to hypovolaemia 4 .
The cause of eclampsia is unknown but cerebral vasospasm [5] [6] [7] [8] is thought to be a major contributory factor. Ergot alkaloids have also been implicated in peripartum cerebral angiopathy 9, 10 . Ergometrine is contraindicated in pre-eclampsia/eclampsia due to the risk of uncontrolled hypertension. It is thus possible that smooth muscle constriction due to ergometrine may have precipitated eclampsia in our patient by exacerbating cerebral vasospasm. Ergot alkaloids are known to have partial agonist/antagonist properties via tryptaminergic and dopaminergic receptors in the central nervous system 11 .
Up to 75% of patients have symptoms heralding the impending onset of eclampsia 12 . Our patient was asymptomatic prior to the infusion. While the development of eclampsia may have been part of her pathological process, the temporal relationship with eclampsia occurring in an asymptomatic patient one hour after an ergometrine bolus suggests a possible causal relationship. The onset of action for ergometrine is rapid and predictable after intravenous injection because it bypasses variable first-pass metabolism, with a mean terminal halflife of 120 minutes. Nonetheless, the duration of action may last up to 24 hours 13 . We speculate that sustained cerebral vasoconstriction for an hour may have eventually precipitated eclampsia in a vulnerable pre-eclamptic patient.
An earlier report attributed the development of post-partum eclampsia to ergometrine administration for post-partum haemorrhage 14 . However, the ergometrine administation occurred eight hours before the onset of eclampsia and was deemed unlikely to be causative 15 .
We believe our case report supports the hypothesis that ergometrine can precipitate eclampsia in undiagnosed cases of pre-eclampsia. It is plausible that the pharmacological effects of ergometrine might exacerbate the pathophysiology of eclampsia.
In the developed world, 1 to 2% and 7 to 9% of pregnancies are complicated by post-partum haemorrhage 16 and pre-eclampsia 17 respectively. Blood loss may delay the development of hypertension and hypertension may be absent in pre-eclampsia. In patients with oliguria, the diagnosis of pre-eclampsia must be considered even in the absence of hypertension because both conditions may co-exist.
While ergometrine is an effective drug for the management of uterine atony, it must be given with caution if there are features potentially consistent with pre-eclampsia-in this case in a parturient with oliguria that was more severe than expected for the degree of blood loss.
